Cara Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference
Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on pruritus.
Read More
Category: US Stocks
Hemp, Inc. CEO Bruce Perlowin Featured in Sinclair Broadcast Coverage About Hemp Stocks Amidst a Congressional Push for Legalization
The published article features commentary from Hemp, Inc. CEO, Bruce Perlowin, regarding the uncertainty of the cannabis industry with a federal ban on the product and massive costs that many investors did not anticipate.
Read More
CV Sciences to Present at the 12th Annual LD Micro Main Event
Joseph Dowling, CV Sciences, Inc. company’s Chief Executive Officer will present at the 12th Annual LD Micro Main Event.
Read More
Green Thumb Industries (GTI) Announces Conference Participation for December 2019
Founder and Chief Executive Officer Ben Kovler will participate in a fireside chat with Cowen Managing Director and Senior Research Analyst Vivien Azer.
Read More
Cara Therapeutics Announces Positive Topline Data From Phase 2 Trial of Oral KORSUVA™ in Chronic Kidney Disease Patients with Moderate-to-Severe Pruritus
Cara Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing new chemical entities.
Read MoreGET LISTED
